Several factors may contribute to this discrepancy, including methodological differences in gene expression data analysis, different composition of discovery cohorts (with respect to representation of various BCP-ALL subtypes, risk groups, and ethnicities), and the limited specificity ofBCR-ABL1 gene expression signature. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.